Medindia

X

Defense Appropriations Funding Will Advance STB(R)'s Development of Lifesaving Dressing

Wednesday, February 24, 2010 General News J E 4
Advertisement


ROCKVILLE, Md., Feb. 23 STB Lifesaving TechnologiesŪ announced today $2.4 million was included in the FY2010 U.S. Department of Defense appropriations bill to advance the development of the Fibrin Adhesive STat (FASTŪ) dressing. This newly developed dressing is designed to be effective against all kinds of blood loss, including severe arterial and venous bleeding and could help save the lives of soldiers suffering from severe blood loss.

According to the Combat Casualty Care Research Program, eighty-six percent of combat-related deaths occur within 30 minutes of wounding, and fifty percent or more are attributable to uncontrolled hemorrhaging. With better products to control bleeding, such as the STB FASTŪ dressing, thousands of military and civilian lives could be saved.

"We are grateful for Senator Cardin's continued support for STBŪ and honored by the opportunity to serve the Department of Defense. If awarded to STBŪ, these funds, along with funds provided by our investors, will be used to accelerate the step up to cGMP manufacturing, and the necessary planning and pre-clinical work required to file for approval by the FDA to initiate human clinical trials," said Ron Peele, STBŪ's President.

Much of the clinical planning will involve advisors from the University of Maryland and MD Shock Trauma Center, who will also be involved in the in vivo efficacy testing, which will be conducted at a facility in Reisterstown, MD.

About STBŪ

Founded in 2005, STB Lifesaving TechnologiesŪ (STBŪ) is a privately held, pre-clinical stage, biotechnology development company located in Rockville, Maryland. STBŪ which stands for "stop the bleeding", is focused on developing a comprehensive suite of products to stop serious and life threatening bleeding in trauma and surgical settings. With a strong proprietary position using its all-natural protein technology with five patents and one provisional patent pending, STBŪ's products will be indispensable to both the military and civilian medical markets.

SOURCE STB Lifesaving Technologies
Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
ATS Medical to Participate in the RBC Capital Mark...
S
Zargis StethAssist & Zargis Cardioscan Cleared for...